2012 Nurse's Drug Handbook |
|
Author:
| Jones and Bartlett Learning Staff, |
ISBN: | 978-1-4496-3864-1 |
Publication Date: | Jul 2011 |
Publisher: | Jones & Bartlett Learning, LLC
|
Book Format: | Paperback |
List Price: | USD $51.95USD $38.50 |
Book Description:
|
A new and updated version of this best-selling resource!Jones and Bartlett Learning 2012 Nurses Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides:* Accurate, timely facts on hundreds of drugs from abacavir sulfate to Zyvox* Concise, consistently formatted drug entries organized alphabetically* No-nonsense writing style that speaks your language in terms you use everyday* Index of all generic, trade, and alternate drug...
More DescriptionA new and updated version of this best-selling resource!Jones and Bartlett Learning 2012 Nurses Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides:* Accurate, timely facts on hundreds of drugs from abacavir sulfate to Zyvox* Concise, consistently formatted drug entries organized alphabetically* No-nonsense writing style that speaks your language in terms you use everyday* Index of all generic, trade, and alternate drug names for quick reference* Chemical and therapeutic classes, FDA pregnancy risk category and controlled substance schedule* Indications and dosages, as well as route, onset, peak, and duration information* Incompatibilities, contraindications; interactions with drugs, food, and activities; and adverse reactions* Nursing considerations, including key patient-teaching points* Vital features include mechanism-of-action illustrations showing how drugs at the cellular, tissue, or organ levels and dosage adjustments help individualize care for elderly patients, patients with renal impairment, and others with special needs* Warnings and precautions that keep you informed and alertNew drug entries include:* Anti-Inhibitor Coagulant Complex* Ceftaroline* Dabigatran* Deferoxamine* Denosumab* Everolimus* Ferumoxytol* Fingolimod* Ibandronate* Lurasidone Dydrochloride* Pegloticase* Tesamorelin